Multiple-Choice Questions on Functional Bladder and Bowel Disorders in Children
Question 1: Initial Management of Dysfunctional Voiding
A 7-year-old girl presents with daytime urinary incontinence and a staccato pattern on uroflowmetry. What is the FIRST-LINE treatment approach?
A) Alpha-blocker therapy (e.g., doxazosin)
B) Anticholinergic medication (e.g., oxybutynin)
C) Urotherapy including education, timed voiding, constipation management, and proper toilet posture
D) Botulinum toxin A injection
Correct Answer: C
Rationale: 1 Urotherapy is the cornerstone of initial management for dysfunctional voiding and should always be attempted before pharmacological interventions. This includes education of the child and family about bladder/bowel dysfunction, timed voiding schedules, adequate fluid intake, aggressive constipation management, and proper toilet posture with foot support and comfortable hip abduction. Success rates with urotherapy and muscle retraining reach 90-100% in comprehensive programs 1. Pharmacological therapy is considered an ancillary measure only after urotherapy has been initiated 1. The multimodal approach outlined in the 2025 EAU guidelines 2 emphasizes standard urotherapy as the foundation before escalating to specific interventions.
Question 2: Diagnostic Evaluation of Dysfunctional Voiding
How many uroflowmetry measurements should be obtained in the same setting to confirm dysfunctional voiding in a well-hydrated child?
A) 1 measurement is sufficient
B) 2 measurements
C) Up to 3 measurements
D) 5 measurements
Correct Answer: C
Rationale: 1 A single abnormal uroflow curve is insufficient for diagnosis because any child can produce a pathological pattern due to stress or tension. The ICCS recommends repeating flow/residual urine measurements up to 3 times in the same setting in a well-hydrated child to ensure a reasonable volume of urine (≥100 mL) is expelled with each void 1. A normal flow curve provides confidence that the child does not have dysfunctional voiding, while repeated abnormal patterns confirm the diagnosis. The typical pattern shows staccato or intermittent flow with reduced maximal flow rate and prolonged flow time 1.
Question 3: Management of Constipation in Bladder-Bowel Dysfunction
What percentage of children with increased post-void residual urine and constipation showed improvement in bladder emptying after treatment of constipation alone?
A) 25%
B) 45%
C) 66%
D) 89%
Correct Answer: C
Rationale: 1 In children presenting with increased post-void residual urine and constipation, 66% had improvement in bladder emptying after treatment for constipation alone 1. This underscores the critical importance of addressing bowel dysfunction concurrently with bladder symptoms. Another study demonstrated that treatment of constipation resulted in 89% resolution of daytime wetting, 63% resolution of nighttime wetting, and prevention of urinary tract infections 1. Aggressive management of constipation with initial disimpaction using oral laxatives followed by a maintenance phase is essential 1, and this program may need to be maintained for many months before the child regains bowel motility and rectal perception.
Question 4: Pharmacological Treatment for Dysfunctional Voiding
Which medication class is recommended to facilitate bladder emptying in children with dysfunctional voiding by targeting the bladder outlet?
A) Muscarinic agonists (e.g., bethanechol)
B) Alpha-adrenergic antagonists (α-blockers)
C) Beta-3 adrenoceptor agonists (e.g., mirabegron)
D) Anticholinergic agents (e.g., oxybutynin)
Correct Answer: B
Rationale: 1 Alpha-adrenergic antagonists (α-blockers) are used to facilitate bladder emptying by targeting the bladder outlet (bladder neck and proximal urethra). Alpha-adrenergic blockade results in smooth muscle relaxation and decreased bladder outlet resistance 1. Muscarinic and cholinergic agonists like bethanechol have NOT been demonstrated to be effective in treating underactive detrusor function 1. Anticholinergics are effective for detrusor overactivity (storage phase) but not for facilitating emptying 1. While α-blockers are currently off-label in children, several reports suggest they facilitate improved emptying in children with dysfunctional voiding 1.
Question 5: Neuromodulation in Refractory Cases
According to the 2025 EAU guidelines, when should neuromodulation (TENS, PTNS, or SNM) be considered in children with daytime lower urinary tract conditions?
A) As first-line treatment before urotherapy
B) As second-line treatment after urotherapy and medical therapy have failed
C) Only in children with neurological abnormalities
D) Only in children over 12 years of age
Correct Answer: B
Rationale: 2 Neuromodulation, including transcutaneous electrical nerve stimulation (TENS), percutaneous tibial nerve stimulation (PTNS), and sacral neuromodulation (SNM), should be considered as second-line treatment after urotherapy and medical therapy have failed 2. The 2025 EAU-ESPU guidelines clearly outline a treatment hierarchy for daytime LUT conditions: standard urotherapy forms the foundation, followed by specific urotherapy (biofeedback, pelvic floor muscle therapy), then medical therapy (anticholinergics, β3-adrenoceptor agonists), and finally neuromodulation or surgical interventions 2. This escalating approach ensures that less invasive, highly effective treatments are exhausted before proceeding to more complex interventions.